Phe­bra phos­phate

Pharmacy Daily - - Front Page -

PHE­BRA has an­nounced the launch of its own brand of Phos­phate 500mg ef­fer­ves­cent tablets to re­place the dis­con­tin­ued Phos­phate San­doz (No­var­tis gener­ics) prod­uct.

Phos­phate Phe­bra is listed on the PBS for the treat­ment of cer­tain dis­eases that cause hy­pophos­phataemia.

Phe­bra CEO Dr Mal Eutick said the com­pany had been work­ing in col­lab­o­ra­tion with No­var­tis “to en­sure that Aus­tralian pa­tients con­tinue to have ac­cess to this clin­i­cally im­por­tant medicine”.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.